Skip to main content
Journal of Lipid Research logoLink to Journal of Lipid Research
. 2010 Sep;51(9):2581–2590. doi: 10.1194/jlr.M005702

Autophagy plays a protective role in free cholesterol overload-induced death of smooth muscle cells

Kedi Xu 1, Yi Yang 1, Ming Yan 1, Jianan Zhan 1, Xiao Fu 1, Xiaoxiang Zheng 1,1
PMCID: PMC2918441  PMID: 20484746

Abstract

Smooth muscle cells (SMC) make up most of the vascular system. In advanced atherosclerotic plaques, dying SMCs undergo a complex death mode. In the present study, we examined the activation of autophagy in SMCs overloaded with excess free cholesterol (FC) and investigated the possible role which autophagy plays during the FC-induced cell death. After incubation with excess FC, a robust expression of autophagic vacuoles (AV) was detected using both fluorescence microscopy and transmission electron microscopy (TEM). The results revealed that FC induced a time-dependent upregulation of microtubule-associated protein-1 light chain 3-II (LC3-II). Inhibition of autophagy by 3-methyladenine (3-MA) enhanced both cell apoptosis and necrosis, while on the contrary, rapamycin inhibited cell death following cholesterol application. Furthermore, the impact of the colocalization of fragmented mitochondria with AVs was observed after cholesterol treatment. Our results also revealed that the modulation of autophagy directly influenced the cellular organellar stress. In conclusion, our findings demonstrated that excess FC induced the activation of autophagy in SMCs as a cellular defense mechanism, possibly through the degradation of dysfunctional organelles such as mitochondria and endoplasmic reticulum.

Keywords: cholesterol, cell death, organellar stress, smooth muscle cell


Smooth muscle cells (SMCs) are the major components of the vascular system. The loss of SMCs in advanced atherosclerotic lesions promotes lesional necrosis, compromises plaque stability, and ultimately triggers thrombotic vascular occlusion (1). In the late stage of atherosclerosis, a great number of SMCs and macrophages that phagocytose lipoproteins accumulate in the intimal layer of arterial wall and develop into “foam cells.” It is proposed that typical apoptosis of macrophages' original foam cell is caused by the intracellular accumulation of unesterified cholesterol (2). However, SMCs are more resistant to the accumulation of free cholesterol (FC) than macrophages (3). Significant increase of apoptotic cell death is not observed until SMCs are incubated with a higher concentration of cholesterol (4). Moreover, the studies using TUNEL technique reported that lipid-laden SMCs rarely undergo apoptosis in early atherosclerotic plaques (5). The investigation of human carotid plaques and plaques from cholesterol-fed rabbits also showed that dying SMCs exhibit typical ultrastructures of autophagic and necrotic cell death (6). These results indicate that SMCs may undergo a complex cell death mode after FC stimulation and that autophagy may provide an alternative mechanism of cell death in lipid-laden SMCs.

Autophagy (specifically macroautophagy) is an evolutionarily conserved catabolic process for subcellular degradation of proteins, organelles, and other cytoplasmic components (7). As the degradation of cellular organelles generates free fatty acids, amino acids, and nucleotides that can be reused to fuel mitochondrial ATP production and maintain protein synthesis, autophagy is considered primarily a cell survival mechanism, especially during nutrient deprivation (8). However, it has also been argued that autophagy may act as an initiator of cell death (9). Excessive autophagic activity may directly destroy a major proportion of the cytosol and organelles, or alternatively, it may trigger apoptosis rather than play a direct role in the death process. For instance, stress in certain organelles, such as mitochondria and endoplasmic reticulum (ER), were indicated as stimulators of autophagic response because autophagy could mediate the specific removal of dysfunctional or damaged cytoplasmic organelles (10, 11). Several pathways that link the apoptotic and autophagic mechanisms also have been described at the molecular level (12). Thus, the result of a common stimulation may be decided by the crosstalk between autophagy and apoptosis or as a result of a cellular “decision” between these two responses.

In our present study, we found that overloading FC triggered autophagy in SMCs. This was confirmed by the conversion of microtubule-associated protein-1 light chain 3-I (LC3-I) to a phosphatidylethanolamine-conjugated form (LC3-II) and the accumulation of autophagic vacuoles (AV) under excess FC conditions. We further discovered that 3-methyladenine (3-MA) suppressed autophagy induced by FC overloading and led to large-scale cell death, whereas preincubation of rapamycin, an autophagy stimulator that inactivates mammalian target of rapamycin (mTOR), protected SMCs from death induced by excess FC. Moreover, the modulation of autophagy influenced the cellular organellar function, suggesting that autophagy played an important role in cell survival after FC overloading.

MATERIALS AND METHODS

Reagents and cell culture

Unless otherwise noted, all reagents and chemicals were purchased from Sigma. Annexin V/propidium iodide (PI), H2DCFDA, and JC-1 were from Invitrogen (CA). Antibody against KDEL (anti-GRP78/GRP94 SPA-827) was purchased from Stressgen (Victoria, Canada). The other antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA).

Primary SMCs were obtained from the aortic media of a male Sprague-Dawley rat with the explants technique. Briefly, thoracic aorta was isolated and cleaned of adventitia and endothelium. The aorta was then cut into 1 mm sections, transferred to a culture dish, and maintained in growth medium of DMEM supplemented with 10% FBS, 2 mM L-glutamine, 4 mM sodium pyruvate, 100 U/ml streptomycin, and 100 U/ml penicillin. The initial migration of SMCs was observed within the first 6 days. After 9 days of migration, these cells were transferred to a new culture dish. All experiments were conducted using SMCs between passage 2 and 5. SMCs were identified by immunocytochemical analysis with anti-α-actin antibody. The purity of the cultures was over 90%.

FC overloading of rat SMCs

Cholesterol was delivered to SMCs by a cholesterol-cyclodextrin complex (Chol:MβCD) that contained approximately 50 mg of cholesterol/g solid (C4951, Sigma). All treatment concentrations were calculated based on cholesterol weight. SMCs were plated on the culture dish until the cells reached 90% confluence. To load excess FC, the monolayer was then incubated with 30 µg/ml Chol:MβCD and the acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor sandoz58035 (58035) (10 µg/ml) in the culture medium for 24 h (4, 13). In some experiments, SMCs were preincubated with 10 mM 3-MA or 1 µM rapamycin for 4 h, followed by the incubation with FC in the presence of 3-MA or rapamycin to modulate the autophagy activity.

Assessment of cell death and cellular ROS concentration with fluorescent dyes

SMCs were collected using a brief trypsin treatment and labeled for 15 min with 5 µg/ml Alexa 488-conjugated Annexin V and 10 µg/ml PI according to the manufacture's protocol. Labeled cells were analyzed with FACScan flow cytometry (Becton-Dickinson, Bedford, MA) using CellQuest software. The percentages of Annexin V- and PI-positive cells were calculated and presented as apoptosis and death percentage, respectively.

To evaluate the concentration of cellular ROS, SMCs were collected and stained with 5 µM H2DCFDA at 37°C for 20 min according to the manufacture's protocol. The mean fluorescence (FL1 channel, excitation 488 nm, emission 530 nm) of labeled cells was determined by flow cytometry.

Visualization of cellular organelles

The pEGFP-LC3 expression vector was a gift from Dr. Yoshimori. Mitochondria were visualized by expression of pDsRed2-mito (Clontech) in SMCs. Transfection was performed one day after subculture with Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. Fluorescence images were obtained using an inverted fluorescent microscope (Olympus IX81; 60×; NA 1.45).

Western blot analysis

SMCs were lysed in an appropriate volume of ice-cold radioimmune precipitation assay buffer containing 1% Triton X-100, 50 mM Tris/HCl, pH 7.4, 300 mM NaCl, 1:100 protease inhibitor cocktail, and 1:100 phosphatase inhibitor cocktail. Equal amounts of protein were loaded to 10% to 15% SDS-polyacrylamide gel. After electrophoresis, proteins were electrotransferred onto polyvinylidene difluoride membrane (Millipore). Membranes were blocked in 5% (w/v) nonfat dry milk for 1 h and probed overnight at 4°C with each primary antibody, followed by incubation with the secondary antibody for 2 h at room temperature. Antibody detection was developed using 3,3,5,5-Tetramethylbenzidine Liquid Substrate kit (Amresco).

Transmission electron microscopy (TEM) analysis

Samples were fixed in 0.1 M sodium cacodylatebuffered (pH 7.4) for 2 h and postfixed in 0.1 M sodium cacodylatebuffered (pH 7.4) 1% OsO4 solution for 1 h. After dehydration in an ethanol gradient [70% (v/v) ethanol (15 min), 80% (v/v) ethanol (15 min), 90% (v/v) ethanol (15 min), 100% ethanol (2 × 20 min)], samples were incubated with propylenoxid (2 × 10 min), impregnated with a mixture of propylenoid/LX-112 (Ladd Research Industries, 1:1), and embedded in LX-112. Ultrathin sections were stained with uranyl acetate and lead citrate. Sections were examined in a Jeol-100 CX II TEM.

Detection and quantification of mitochondrial membrane potential (Δϕm)

To evaluate the depolarization of mitochondria, SMCs were collected and stained with 5 µM JC-1 at 37°C for 20 min according to the manufacture's protocol. JC-1 undergoes aggregation within the mitochondrial matrix above a critical threshold concentration. JC-1 aggregations appear as red fluorescence (the FL2 channel of flow cytometry, excitation 488 nm, emission 585 nm), whereas the monomer of JC-1 appears as green fluorescence (FL1 channel). Mitochondrial depolarization will, therefore, decrease the concentration of red JC-1 aggregates and increase the green fluorescence (14). Thus, mean red (FL2) and green (FL1) fluorescence were determined by flow cytometry for subsequent calculation of mean FL2:FL1 ratio, which was used as a semi-quantitative monitor of Δϕm.

Statistical analysis

The data were plotted as mean ± SEM from three independent experiments. Statistical significant differences were carried out by one-way ANOVA followed by Tukey's posthoc tests. P < 0.01 was considered statistically significant.

RESULTS

FC loading induced complex SMC death

In our previous work, treatment of SMCs with excess FC rapidly induced cell death (Fig. 1A) via the mitochondrial and ER-dependent death pathway with widespread cellular organelle dysfunction (4). To further explore the mechanism of FC overload-induced cell death, SMCs were pretreated with Z-vad-fmk, a pan-caspase inhibitor that blocks cell apoptosis, and incubated with FC in the presence of Z-vad-fmk for 24 h. As shown in Fig. 1B and C, the caspase inhibitor had no effect on the protection of SMCs under the lipid-laden condition as it led to a slight decrease in the percentage of apoptotic (Annexin V positive) cells but significant increase in the necrotic percentage (PI positive). Furthermore, FC overload-induced SMC death was accompanied with an upregulation of cellular reactive oxygen species (ROS), which we previously believed to be a major inducer of cell death. Two widely used antioxidants, y-L-glutamyl-L-cysteinyl-glycine (GSH) and N-acetylcysteine (NAC), were used to reduce the production of cellular ROS. Unexpectedly, neither GSH nor NAC could protect SMCs from FC-induced cell death, though both antioxidants recovered the cellular ROS level (Fig. 1D). These results suggested that apoptosis might not be the only pathway involved in FC overload-induced SMC death and that other mechanisms, such as autophagy and necrosis, might contribute to this complex mode of cell death.

Fig. 1.

Fig. 1.

FC overloading induced complex SMC death. A: Photomicrograph of normal SMCs (Control, left) or SMCs treated with Chol:MβCD plus sandoz58035 (Chol+58035, right) for 24 h. B: Representative flow cytometry data for different samples. SMCs were treated with excess FC (Chol+58035) or FC plus 20 µM Z-vad-fmk (Chol+58035+Z-vad) for 24 h. The X-axis is the fluorescence intensity of Annexin V, and the Y-axis is the fluorescence intensity of PI. C: Percentage of Annexin V and PI labeling cells with different treatment. D: Death percentage (PI positive plus Annexin V positive) and the intracellular ROS concentration of SMCs pretreated with 10 mM GSH or NAC for 4 h followed by 24 h treatment of FC plus GSH or NAC. Data correspond to mean ± SEM, n = 6, ***P < 0.001 compared with control group; ##P < 0.01, ###P < 0.001 compared with Chol+58035 group. Scale bar, 50 µm. Chol:MβCD, cholesterol-cyclodextrin complex; FC, free cholesterol; GSH, y-L-glutamyl-L-cysteinyl-glycine; PI, propidium iodide; ROS, reactive oxygen species; SMC, smooth muscle cell.

Autophagy was activated in FC-overloaded SMCs

Since the formation of AVs is by far the most important feature of autophagy, demonstration of these structures by electron microscopy is considered the gold standard for documenting autophagy. Hence, we examined the ultrastructural changes in SMCs upon cholesterol treatment. AVs were rarely detected in either normal SMCs (Fig. 2A, a, b) or SMCs incubated with Chol:MβCD alone (Fig. 2A, c, d). After overloading SMCs with FC for 24 h, a large number of AVs formed and were distributed throughout the whole cytoplasm (Fig. 2A, e–h, and ). Most of the AVs contained the remnants of cellular organelles (black arrows in Fig. 2A, f). Mild to extensive autophagic vacuolizations were also observed in FC-overloaded SMCs (Fig. 2A, e–h, and 2B). Note that no pronounced chromatin condensation in the nucleus was presented in any specimens.

Fig. 2.

Fig. 2.

TEM micrographs of autophagic vacuoles. A: Representative electron micrographs of normal SMCs (a, b), SMCs incubated with Chol:MβCD for 24 h (c, d), and SMCs treated with Chol:MβCD plus sandoz58035 (e–h). AVs contain the remnants of cellular organelles, such as mitochondria and ER (indicated by black arrows). Myelin figure-like structures are indicated by white arrows. N = nucleus. Scale bar = 2 µm or 0.5 µm. B: The average number of AVs present in normal SMCs, Chol:MβCD-treated SMCs (Cholesterol), and FC-overloaded SMCs (Chol+58035). ***P < 0.001 compared with control group. AV, autophagic vacuole; Chol:MβCD, cholesterol-cyclodextrin complex; ER, endoplasmic reticulum; FC, free cholesterol; SMC, smooth muscle cell.

The AV formation in living cells was determined by fluorescence microscopy. As shown in Fig. 3A, in normal SMCs, most GFP-LC3 protein was distributed diffusely throughout the whole cell, although a small part of normal SMCs contained low-level punctual fluorescence dots (especially in SMCs after long-term culture). After treatment with excess FC, diffuse cytoplasmic forms were redistributed to discrete vesicular structures of GFP-LC3, suggesting the activation of autophagy. The formation of vesicular structures was absent in SMCs pretreated with the specific autophagy inhibitor 3-MA. Autophagy induction was further confirmed by Western blotting analysis with anti-LC3 antibody. Overloading SMCs with FC caused a significant and time-dependent increase in the expression of the autophagy-indicative LC3-II. The ratio of LC3-II:LC3-I was enhanced appreciably after a 12 h treatment, and a robust production of LC3-II was observed after a 24 h treatment (Fig. 3B, C). These results further strengthened the hypothesis that autophagy was activated in FC-treated SMCs.

Fig. 3.

Fig. 3.

FC overloading activated autophagy in SMCs. A: The AVs formation in FC-overloaded SMCs (Chol+58035). Cells were transfected with an expression vector for GFP-LC3 and then stimulated with FC for 12 h or 24 h. The GFP-LC3 dot formation was inhibited by pretreatment with 10 mM 3-MA (Chol+58035+3MA). B: Western blot of LC3-I and LC3-II in SMCs after incubation with excess FC for different incubation time. FC overloading caused a time-dependent increase in the expression of the autophagy-indicative LC3-II. C: The quantitative analysis of Fig. 3B. The ratio of LC3-II:LC3-I and LC3-II:actin was appreciably enhanced after 12 h FC treatment, while the ratio of LC3-I:actin appeared stable. Scale bar, 10 µm. AV, autophagic vacuole; LC3, microtubule-associated protein-1 light chain 3; 3-MA, 3-methyladenine; SMC, smooth muscle cell.

Autophagy provided protection from FC overload-induced cell death

To further clarify the function of autophagy as a pro-death or pro-survival pathway in FC-overloaded SMCs, both autophagy inhibitor and inducer were applied. 3-MA was reported to suppress autophagic activity by preventing the formation of AVs (15). In our experiments, the expression of LC3-II was dramatically low in SMCs pretreated with 10 mM 3-MA for 4 h followed by 24 h incubation with FC in the presence of 3-MA (Fig. 4B, C). Meanwhile, 3-MA significantly triggered cell apoptosis and death in FC-overloaded SMCs (Fig. 4A, 16.4 ± 2.0% for annexin V-positive and 28.5 ± 3.7% for PI-positive, both upregulated about three times compared with the model group). Next, we investigated whether induction of autophagy with rapamycin could have a protective effect from FC overload-induced cell death(Fig. 4B, C). SMCs treated with rapamycin exhibited a reduced susceptibility to the excess FC treatment, as demonstrated by a lower annexin V- and PI-positive cell percentage. However, this protective effect was not complete, and it was entirely reversed when the FC-overloaded cells were simultaneously treated with 3-MA plus rapamycin, suggesting that the protective effect of rapamycin was blocked when autophagy was inhibited (Fig. 4A).

Fig. 4.

Fig. 4.

Modulation of autophagy-impacted cell death in FC-overloaded SMCs. A: SMCs were incubated with FC in the presence of 10 mM 3-MA and/or 1µM rapamycin for 24 h. Both 3-MA and rapamycin were added 4 h before FC treatment. The percentage of apoptosis and necrosis were then assessed. B: Western blot of LC3-I and LC3-II expression in SMCs after incubation with excess FC plus 3MA or rapamycin. C: The ratio of LC3-II:LC3-I in 3MA- or rapamycin-treated SMCs. Data correspond to mean ± SEM, n = 6, *P < 0.05, **P < 0.01, ***P < 0.001 compared with control group; #P < 0.05, ##P < 0.01, ###P < 0.001 compared with Chol+58035 group; ††P < 0.01, †††P < 0.001 compared with Chol+58035+Rapa group. FC, free cholesterol; LC3, microtubule-associated protein-1 light chain 3; 3-MA, 3-methyladenine; SMC, smooth muscle cell.

Enhanced autophagy activity reduced mitochondrial and ER stress

A possible mechanism for the protective effect of autophagy was that autophagy accelerated the clearance of impaired cellular organelles. To verify this hypothesis, SMCs were cotransfected with DsRed2-Mitochondria and GFP-LC3 plasmids. As illustrated in Fig. 5A, in normal SMCs, most LC3 protein was distributed diffusely throughout the whole cell without colocalization of DsRed2- labeled mitochondria and GFP-LC3-labeled AVs. The FC overload induced the formation of punctual AVs and the fragmentation of mitochondria (Fig. 5A, middle line). The colocalization of AVs and mitochondria were more frequently detected after 24 h treatment with FC (Fig. 5A, white arrows in the last line). We then measured the Δϕm to estimate the mitochondrial function. The inhibition of autophagy by 3-MA resulted in an apparent reduction in the ratios of red (FL2) to green (FL1) fluorescence, indicating a large-scale mitochondrial depolarization. Conversely, SMCs incubated with FC plus rapamycin maintained a better Δϕm condition than those overloaded with FC (Fig. 5B). Furthermore, both GRP78 and GRP94 protein levels, a positive symbol of unfolded protein response (UPR) activation and ER stress, declined after rapamycin treatment and rose with 3-MA treatment (Fig. 5C, D). These results illustrated that autophagy acted as a cellular defense mechanism and promoted cell survival in FC-overloaded SMCs, possibly by facilitating the clearance of impaired cellular organelles.

Fig. 5.

Fig. 5.

Modulation of the autophagy activity impaired the clearance of dysfunctional cellular organelles. A: Effect of FC on the colocalization of mitochondria and AVs. SMCs were transfected with pDsRed2-mito and pEGFP-LC3, followed with (Chol+58035) or without (Control) FC incubation. White arrows illustrated the colocalization of AVs and mitochondria. B: Estimation of mitochondrial membrane potential by JC-1 after modulation of autophagy activity in FC-overloaded SMCs. The ratio of mean red (FL2) and green (FL1) fluorescence is presented in the right panel. C: Pretreatment with rapamycin reduced the expression of the UPR-upregulated target proteins GRP78 and GRP94. D: ER stress was upregulated in SMCs pretreated with 3-MA. Data correspond to mean ± SEM, n = 3; *P < 0.05, **P < 0.01, ***P < 0.001 compared with control group; #P < 0.05, ##P < 0.01, ###P < 0.001 compared with Chol+58035 group. Scale bar, 10 µm. AV, autophagic vacuole; FC, free cholesterol; SMC, smooth muscle cell; UPR, unfolded protein response.

DISCUSSION

FC overload-induced vascular cell death is considered an important event in progression of atherosclerosis. Recently, Feng reported that excess intracellular FC triggered macrophage death with the characteristics of apoptosis (2). In our previous study, FC was also found to be a potent inducer of rat aortic SMC death; both mitochondrial- and ER-dependent apoptotic signal pathways were involved in FC-induced SMC death (4). However, the present study demonstrated that apoptosis may not be the only manner of FC overload-induced SMC death. In contrast to the FC overload-induced macrophage death, only a small increase of annexin V labeling was noticed after excess FC treatment, and the caspase inhibitor z-vad-fmk could not rescue SMCs from cell death. Although the FC-overloaded SMCs presented a high level of cellular ROS accompanied by the loss of Δϕm, antioxidants such as GSH and NAC failed to extenuate cell death. On the other hand, autophagy was also involved in FC overload-induced cell death. The activation of autophagy was observed from the formation of punctual AVs and increasing LC3-II conversion and was further confirmed by TEM analysis. Large-scale damage of cellular organelles, including mitochondria and ER, was observed after SMCs were incubated with excess FC. Most of the AVs in the FC-overloaded SMCs contained the remnants of these cellular organelles, which indicated that excess FC induced severe cellular organelle damage and that these cellular organelles might be cleared through autophagy. Thus, the present study illustrated that, after overloaded with FC, SMCs underwent a complex mode of cell death that involved apoptosis, autophagy, and to some extent, necrosis.

Emerging lines of evidence have revealed the potential link between autophagy and apoptosis (12). Autophagy and apoptosis can be elicited by common upstream regulators, such as impaired cellular organelles. The dysfunction of mitochondria, formerly recognized as an initial event in cell apoptosis, is now also identified as a trigger of autophagy. Mitochondria can undergo the so-called permeability transition, in which a sudden increase in the permeability of the inner membrane causes the loss of Δϕm and may trigger the engulfment of depolarized mitochondria by autophagy (16). Several studies have mentioned that autophagy is activated for cell survival after ER stress and requires the action of the UPR regulator GRP78/Bip (10, 17). Consistent with these observations, we found that the upregulation of GRP78 and activation of UPR participated in FC overload-induced cell death.

Several signal pathways may also be involved in the crosstalk between apoptosis and autophagy. For example, the autophagy protein-6 (ATG6, also known as Beclin1) was identified as a Bcl-2-interacting protein. The autophagy-inducing activity of ATG6 could be inhibited by Bcl2 family, indicating an association between molecules regulating autophagy and apoptosis (18). Death-associated protein kinase (DAPK) and DAPK-related protein-1, which regulates membrane blebbing during apoptosis, can also control the autophagic vacuole formation (19). Thus, in some instances, autophagy and apoptosis could be induced by the same stimuli, could share similar effectors and regulators, and could be subjected to complex crosstalk mechanisms.

The precise role of autophagy in FC overload-induced SMCs death is still poorly understood. Autophagy is generally thought as an evolutionarily conserved mechanism for the degradation of cellular components that serves as a survival mechanism in starving cells (20). However, recent reports point out that autophagy might also contribute to cell death, although the detailed mechanism with regard to autophagy and apoptosis is unclear. It appears that, in several circumstances, autophagy acts in a housekeeping role and offers protection against cell death, whereas in other circumstances, it constitutes an alternative cell-death pathway. Inhibition of autophagy by 3-MA could actually activate apoptosis (21). Conversely, induction of autophagy might have an apoptosis-inhibitory effect through the removal of damaged organelles or misfolded proteins. Pretreatment of cells with rapamycin can reduce mitochondria load to ∼50% while having a protective effect against pro-apoptotic insults (22). In our present experiments, it seems more likely that autophagy served a self-protective role that promoted cell survival in FC-overloaded SMCs. Pretreatment with rapamycin stabilized Δϕm and decreased FC overload-induced ER stress. However, we cannot exclude the possibility that autophagy may also play an active role in FC overload-induced SMC death. Autophagy may provide intrinsic degradation machinery under certain cellular stress. However, when beyond a certain threshold, it could also cause irreversible cellular atrophy and, finally, the collapse of whole cellular function. In our study, large-scale formation of AVs was observed by TEM analysis; in some cases, most of the intracellular volume was occupied by AVs. Therefore, this excessive autophagic activity is capable of destroying major proportions of cellular organelles and may finally lead to cellular demise.

A large amount of evidence indicates that SMCs in advanced human atherosclerotic plaques show signs of apoptotic and nonapoptotic cell death. Accumulation of FC can be observed in foam-cell like macrophages or SMCs in advanced plaques, but these cells usually do not undergo apoptotic cell death. Similar to our finding, activation of autophagy in SMCs was also reported in several other in vitro experiments (23). Exposure to the products of lipid peroxidation, such as 4-hydroxynonenal (4-HNE), activated autophagy in cultured rat aortic SMCs, and inhibition of autophagy by 3-MA caused 4-HNE-induced cell death (24). 7-ketocholesterol, one of the major oxysterols present in oxLDL, triggered not only oxidative damage but also extensive vacuolization, depletion of cellular organelles, and LC3-II conversion in SMCs (25). Moreover, lipid-laden SMCs in human plaques and cultured SMCs upregulated DAPK, a positive mediator of AV formation (19). On the other hand, Singh reported that autophagy played a critical role in lipid metabolism and could have important implications for human diseases (26). Several pharmacologic studies have been tested for the therapeutic application of autophagy in atherosclerosis (27). SMCs apoptosis induced by statins was attenuated by the autophagy inducer 7-ketocholesterol (28). Inhibition of mTOR by rapamycin or its analogs led to autophagic cell death and might be used for selective clearance of macrophages in atherosclerotic plaques (29, 30). All these results support the hypothesis that understanding autophagy might ultimately allow scientists to harness this process in the treatment for atherosclerosis (31, 32).

CONCLUSION

Our findings demonstrated that FC-overloaded SMCs underwent a complex mode of cell death. The excess intracellular FC led to large-scale cellular organelles damage, which further activated the formation of AVs and LC3 processing. During this process, enhanced autophagy became involved in a prosurvival mechanism that prevented cell death in FC-overloaded SMCs. One possible explanation for this observation is that the induction of autophagy resulted in the clearance of impaired cellular organelles and reduced organellar stress that finally protected SMCs from the death stimuli.

Footnotes

Abbreviations:

ATG6
autophagy protein-6
AV
autophagic vacuole
Chol:MβCD
cholesterol-cyclodextrin complex
DAPK
death-associated protein kinase
Δϕm
mitochondrial membrane potential
ER
endoplasmic reticulum
FC
free cholesterol
GSH
y-L-glutamyl-L-cysteinyl-glycine
4-HNE
4-hydroxynonenal
LC3
microtubule-associated protein-1 light chain 3
3-MA
3-methyladenine
NAC
N-acetylcysteine
PI
propidium iodide
ROS
reactive oxygen species
SMC
smooth muscle cell
TEM
transmission electron microscopy
mTOR
mammalian target of rapamycin
UPR
unfolded protein response

This work was supported by the Key Laboratory of Biomedical Engineering of the Ministry of China and by the Key Laboratory of Chinese Medicine Screening, Exploitation and Medicinal Effectiveness Appraisal for Cardio-cerebral Vascular and Nervous System of Zhejiang Province.

REFERENCES

  • 1.Kockx M. M. 1998. Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler. Thromb. Vasc. Biol. 18: 1519–1522. [DOI] [PubMed] [Google Scholar]
  • 2.Feng B., Yao P. M., Li Y., Devlin C. M., Zhang D., Harding H. P., Sweeney M., Rong J. X., Kuriakose G., Fisher E. A., et al. 2003. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat. Cell Biol. 5: 781–792. [DOI] [PubMed] [Google Scholar]
  • 3.Rong J. X., Kusunoki J., Oelkers P., Sturley S. L., Fisher E. A. 2005. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation. Arterioscler. Thromb. Vasc. Biol. 25: 122–127. [DOI] [PubMed] [Google Scholar]
  • 4.Kedi X., Ming Y., Yongping W., Yi Y., Xiaoxiang Z. 2009. Free cholesterol overloading induced smooth muscle cells death and activated both ER- and mitochondrial-dependent death pathway. Atherosclerosis. 207: 123–130. [DOI] [PubMed] [Google Scholar]
  • 5.Hegyi L., Skepper J. N., Cary N. R., Mitchinson M. J. 1996. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J. Pathol. 180: 423–429. [DOI] [PubMed] [Google Scholar]
  • 6.Kockx M. M., De Meyer G. R., Buyssens N., Knaapen M. W., Bult H., Herman A. G. 1998. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ. Res. 83: 378–387. [DOI] [PubMed] [Google Scholar]
  • 7.Baehrecke E. H. 2005. Autophagy: dual roles in life and death? Nat. Rev. Mol. Cell Biol. 6: 505–510. [DOI] [PubMed] [Google Scholar]
  • 8.Yang Y., Fukui K., Koike T., Zheng X. 2007. Induction of autophagy in neurite degeneration of mouse superior cervical ganglion neurons. Eur. J. Neurosci. 26: 2979–2988. [DOI] [PubMed] [Google Scholar]
  • 9.Levine B., Yuan J. 2005. Autophagy in cell death: an innocent convict? J. Clin. Invest. 115: 2679–2688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Yorimitsu T., Nair U., Yang Z., Klionsky D. J. 2006. Endoplasmic reticulum stress triggers autophagy. J. Biol. Chem. 281: 30299–30304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kiffin R., Bandyopadhyay U., Cuervo A. M. 2006. Oxidative stress and autophagy. Antioxid. Redox Signal. 8: 152–162. [DOI] [PubMed] [Google Scholar]
  • 12.Maiuri M. C., Zalckvar E., Kimchi A., Kroemer G. 2007. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 8: 741–752. [DOI] [PubMed] [Google Scholar]
  • 13.Rong J. X., Shapiro M., Trogan E., Fisher E. A. 2003. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc. Natl. Acad. Sci. USA. 100: 13531–13536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Nicholls D. G., Ward M. W. 2000. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci. 23: 166–174. [DOI] [PubMed] [Google Scholar]
  • 15.Lum J. J., Bauer D. E., Kong M., Harris M. H., Li C., Lindsten T., Thompson C. B. 2005. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 120: 237–248. [DOI] [PubMed] [Google Scholar]
  • 16.Rodriguez-Enriquez S., Kim I., Currin R. T., Lemasters J. J. 2006. Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat hepatocytes. Autophagy. 2: 39–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Li J., Ni M., Lee B., Barron E., Hinton D. R., Lee A. S. 2008. The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells. Cell Death Differ. 15: 1460–1471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Maiuri M. C., Le Toumelin G., Criollo A., Rain J. C., Gautier F., Juin P., Tasdemir E., Pierron G., Troulinaki K., Tavernarakis N., et al. 2007. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 26: 2527–2539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Inbal B., Bialik S., Sabanay I., Shani G., Kimchi A. 2002. DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J. Cell Biol. 157: 455–468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wu Y. T., Tan H. L., Huang Q., Kim Y. S., Pan N., Ong W. Y., Liu Z. G., Ong C. N., Shen H. M. 2008. Autophagy plays a protective role during zVAD-induced necrotic cell death. Autophagy. 4: 457–466. [DOI] [PubMed] [Google Scholar]
  • 21.Boya P., Gonzalez-Polo R. A., Casares N., Perfettini J. L., Dessen P., Larochette N., Metivier D., Meley D., Souquere S., Yoshimori T., et al. 2005. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 25: 1025–1040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ravikumar B., Berger Z., Vacher C., O'Kane C. J., Rubinsztein D. C. 2006. Rapamycin pre-treatment protects against apoptosis. Hum. Mol. Genet. 15: 1209–1216. [DOI] [PubMed] [Google Scholar]
  • 23.Martinet W., De Meyer G. R. 2008. Autophagy in atherosclerosis. Curr. Atheroscler. Rep. 10: 216–223. [DOI] [PubMed] [Google Scholar]
  • 24.Hill B. G., Haberzettl P., Ahmed Y., Srivastava S., Bhatnagar A. 2008. Unsaturated lipid peroxidation-derived aldehydes activate autophagy in vascular smooth-muscle cells. Biochem. J. 410: 525–534. [DOI] [PubMed] [Google Scholar]
  • 25.Martinet W., De Bie M., Schrijvers D. M., De Meyer G. R., Herman A. G., Kockx M. M. 2004. 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 24: 2296–2301. [DOI] [PubMed] [Google Scholar]
  • 26.Singh R., Kaushik S., Wang Y., Xiang Y., Novak I., Komatsu M., Tanaka K., Cuervo A. M., Czaja M. J. 2009. Autophagy regulates lipid metabolism. Nature. 458: 1131–1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Martinet W., De Meyer G. R. 2009. Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ. Res. 104: 304–317. [DOI] [PubMed] [Google Scholar]
  • 28.Martinet W., Schrijvers D. M., Timmermans J. P., Bult H. 2008. Interactions between cell death induced by statins and 7-ketocholesterol in rabbit aorta smooth muscle cells. Br. J. Pharmacol. 154: 1236–1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Martinet W., Verheye S., De Meyer G. R. 2007. Everolimus-induced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy. Autophagy. 3: 241–244. [DOI] [PubMed] [Google Scholar]
  • 30.Verheye S., Martinet W., Kockx M. M., Knaapen M. W., Salu K., Timmermans J. P., Ellis J. T., Kilpatrick D. L., De Meyer G. R. 2007. Selective clearance of macrophages in atherosclerotic plaques by autophagy. J. Am. Coll. Cardiol. 49: 706–715. [DOI] [PubMed] [Google Scholar]
  • 31.Mizushima N., Levine B., Cuervo A. M., Klionsky D. J. 2008. Autophagy fights disease through cellular self-digestion. Nature. 451: 1069–1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Rubinsztein D. C., Gestwicki J. E., Murphy L. O., Klionsky D. J. 2007. Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov. 6: 304–312. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Lipid Research are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES